C De Vigan1, B Khoshnood, A Lhomme, V Vodovar, J Goujard, F Goffinet. 1. Registre des malformations congénitales de Paris, INSERM U 149, Recherches épidémiologiques en santé périnatale et santé des femmes, 16, avenue Paul-Vaillant-Couturier, 94807 Villejuif Cedex. devigan@vjf.inserm.fr
Abstract
OBJECTIVES: To assess overall and malformation-specific trends in the prevalence, prenatal diagnosis and pregnancy termination of congenital malformations in the Parisian population. METHODS: We used data from the Paris Registry of Congenital Malformations, which includes all births and pregnancy terminations with structural birth defects or chromosomal anomalies. Data on total and live birth prevalence were available for the period 1981-2000 and for prenatal diagnosis and pregnancy terminations for 1983-2000. Twenty malformations were selected for malformation-specific analyses due to their higher frequency and consistent definitions in different classification systems. RESULTS: For the period 1981-2000, the overall total prevalence of malformations was 3.2%. Prenatal diagnosis rates consistently increased from 16.2% (95% CI, 13.8-18.6) of cases with malformation in 1983 to 69.1% (95% CI, 66.7-71.5) in 2000. Pregnancy terminations increased from 8.8% (95% CI, 7.0-10.8) of cases with malformation in 1983 to 30.1% (95% CI, 27.7-32.6) in 2000. CONCLUSION: Registries of congenital malformations provide population-based data on the prevalence of malformations and their associations with other anomalies. Registry-based data can also be used to evaluate the impact of prenatal testing policies for congenital malformations.
OBJECTIVES: To assess overall and malformation-specific trends in the prevalence, prenatal diagnosis and pregnancy termination of congenital malformations in the Parisian population. METHODS: We used data from the Paris Registry of Congenital Malformations, which includes all births and pregnancy terminations with structural birth defects or chromosomal anomalies. Data on total and live birth prevalence were available for the period 1981-2000 and for prenatal diagnosis and pregnancy terminations for 1983-2000. Twenty malformations were selected for malformation-specific analyses due to their higher frequency and consistent definitions in different classification systems. RESULTS: For the period 1981-2000, the overall total prevalence of malformations was 3.2%. Prenatal diagnosis rates consistently increased from 16.2% (95% CI, 13.8-18.6) of cases with malformation in 1983 to 69.1% (95% CI, 66.7-71.5) in 2000. Pregnancy terminations increased from 8.8% (95% CI, 7.0-10.8) of cases with malformation in 1983 to 30.1% (95% CI, 27.7-32.6) in 2000. CONCLUSION: Registries of congenital malformations provide population-based data on the prevalence of malformations and their associations with other anomalies. Registry-based data can also be used to evaluate the impact of prenatal testing policies for congenital malformations.
Authors: I Lacroix; C Hurault; M F Sarramon; C Guitard; A Berrebi; M Grau; C Albouy-Cossard; R Bourrel; E Elefant; J L Montastruc; C Damase-Michel Journal: Eur J Clin Pharmacol Date: 2009-04-14 Impact factor: 2.953
Authors: Natasha Nassar; Emanuele Leoncini; Emmanuelle Amar; Jazmín Arteaga-Vázquez; Marian K Bakker; Carol Bower; Mark A Canfield; Eduardo E Castilla; Guido Cocchi; Adolfo Correa; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Babak Khoshnood; Danielle Landau; Nathalie Lelong; Jorge S López-Camelo; R Brian Lowry; Robert McDonnell; Paul Merlob; Julia Métneki; Margery Morgan; Osvaldo M Mutchinick; Miland N Palmer; Anke Rissmann; Csaba Siffel; Antonin Sìpek; Elena Szabova; David Tucker; Pierpaolo Mastroiacovo Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-09-03
Authors: Catherine Verret; Mathe-Aline Jutand; Catherine De Vigan; Marion Bégassat; Lynda Bensefa-Colas; Patrick Brochard; Roger Salamon Journal: BMC Public Health Date: 2008-04-28 Impact factor: 3.295